Australia markets close in 5 hours 41 minutes

AbCellera Biologics Inc. (ABCL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
11.91-0.80 (-6.29%)
At close: 04:00PM EST
11.77 -0.14 (-1.18%)
After hours: 06:19PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
603,210
375,203
233,155
11,612
8,831
Cost of revenue
86,776
45,516
27,143
-
0
Gross profit
516,434
329,687
206,012
-
8,831
Operating expenses
Research development
96,843
62,062
29,393
10,113
5,803
Selling general and administrative
65,766
48,761
15,752
4,012
2,863
Total operating expenses
166,401
107,788
41,661
13,954
7,990
Operating income or loss
350,033
221,899
164,351
-2,343
841
Interest expense
-
5,225
6,511
209.196
212
Total other income/expenses net
7,083
-855
-300
186.056
-362
Income before tax
355,221
219,149
157,833
-2,211
309
Income tax expense
106,861
65,685
38,915
-
0
Income from continuing operations
248,360
153,464
118,918
-2,211
309
Net income
248,360
153,464
118,918
-2,211
309
Net income available to common shareholders
248,360
153,464
85,101
-2,211
292
Basic EPS
-
0.56
0.53
-0.01
0.00
Diluted EPS
-
0.48
0.45
-0.01
0.00
Basic average shares
-
275,764
159,195
172,380
215,415
Diluted average shares
-
318,294
263,130
172,380
237,724
EBITDA
-
241,624
169,615
-154.612
1,439